Pacira BioSciences Inc — Liquidità Trimestrale (NASDAQ:PCRX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 1.55 B1.59 B1.54 B1.3 B1.26 B Totale passività 775.17 M788.13 M779.5 M570.36 M571.81 M Patrimonio netto totale 778.35 M798.54 M757.77 M727.21 M693.11 M Totale passività e patrimonio netto 1.55 B1.59 B1.54 B1.3 B1.26 B Debito totale 585.32 M583.38 M580.49 M376.72 M372.19 M Indebitamento netto 100.71 M89.75 M134.63 M130.39 M133.76 M

Notizie

DOMA Perpetual nominates three directors to Pacira board

Pacira Faces Board Fight As Activist Investor Criticizes CEO Pay, Missed Earnings - Pacira BioSciences (NASDAQ:PCRX)

Pacira alla Conferenza Barclays: Approfondimenti Strategici e Piani di Crescita

Pacira at Barclays Conference: Strategic Insights and Growth Plans

Pacira BioSciences risponde alle nomine di amministratori di DOMA

Pacira BioSciences responds to DOMA director nominations

Pacira BioSciences, Inc. (PCRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Le azioni Pacira BioSciences salgono del 2% mentre un attivista chiede la rimozione del CEO

Pacira BioSciences shares rise 2% as activist pushes for CEO removal

Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Compared to Estimates, Pacira (PCRX) Q4 Earnings: A Look at Key Metrics